Drug Information Association Logo
Corporate Tagline

Series: The Impact of Drug Shortages on the Pharmaceutical Industry Part 2: Drug Shortages within the Pharmaceutical Supply Chain: Impact on Patient Safety and Gray Market Control

| Online

« Back to Listing

Overview 

Continuing Education Credits or Certificate Program units are not available for Archive Webinars.


Drug shortages continue to threaten the health care industry, and health care providers are faced with trying to understand the shortages and their effect on patient safety. In this webinar, the gray market in the pharmaceutical supply chain will be discussed as well as the affect of drug shortages on patient safety.

Archived Webinar available through June 5, 2013.

Who Should Attend 

Manufacturers, Distributers, Purchasing Organizations, Regulatory Bodies and Policy Makers:

  • Regulatory Affairs
  • Clinical Safety/Pharmacovigilance
  • Pricing/Reimbursement
  • Public Policy/Law/Corp. Compliance
  • Quality Assurance/Quality Control
  • Strategic Planning
  • Sales and Marketing

Learning Objectives 

At the conclusion of this webinar, participants should be able to:
• Explain the gray market in the pharmaceutical supply chain
• Discuss how drug shortages affect patient safety

Special Offers 

Save up to 20 percent by registering online in one transaction for multiple webinars in this series. (Special pricing valid for online registrations by individuals and groups.)

Contact Information 

For questions about Archived Webinars
Carolyn Callahan
DIA North America
Phone +1.215.442.6180
Fax +1.215.442.6199
Carolyn.Callahan@diahome.org

Technical Requirements 

Click here for minimum system requirements.

Presenter(s) 

Previous Next

Agenda  

Day 1 Thursday, May 17, 2012

  • 12:00AM - 11:59PM

    Series: The Impact of Drug Shortages on the Pharmaceutical Industry Part 2: Drug Shortages within the Pharmaceutical Supply Chain: Impact on Patient Safety and Gray Market Control

    Speaker(s):

    • Drug Shortages Within the Pharmaceutical Supply Chain: Impact on Patient Safety and Gray Market Control
      Eleni Anagnostiadis
      Consumer Safety Officer
      Center For Drug Evaluation & Research (CDER), FDA, United States
    • Drug Shortages Within the Pharmaceutical Supply Chain: Impact on Patient Safety and Grey Market Controls
      Steve Mays
      Sr. Director, Corporate Security & Regulatory Affairs
      Amerisource Bergen Corporation, United States

Registration Fees 

Other Fees

Government (Full Time) Individual
$125.00
Charitable Nonprofit/Academia Individual
$175.00
Group Site
$799.00
Group Plus
$995.00

Member

Member Individual
$250.00

Non-Member

NonMember Individual
$295.00
Register Online
« Back to Listing Back To Top